NCT03366766 2026-02-20Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung CancerThomas Jefferson UniversityPhase 2 Terminated14 enrolled 16 charts